@author-1788515151757110
启明创投致力于成为中国优秀技术创业者们的首选投资机构
Focused on developing first-in-class and best-in-class Class 1 innovative drugs with global intellectual property rights, with a focus on oncology and chronic disease therapeutics.
A biotech company focused on generative AI-powered antibody drug development
The compilation and release of the frontrunner rankings is a key initiative for identifying forward-looking trends, exploring the frontiers of technology, and establishing a "weather vane" for industry development.
WeRide is the Chinese autonomous driving company with the broadest international footprint and the most comprehensive product portfolio, and it is also the only technology company in the world whose products hold autonomous driving permits in seven countries.
Innovative companies in the global in vivo cell therapy space
Staying with you to mark milestone moments for Qiming Venture Partners' portfolio companies
This marks the fourth consecutive year that Qiming Venture Partners has hosted this event, which to date has facilitated hundreds of one-on-one meetings for over a hundred leading global pharmaceutical and investment companies, laying a solid foundation for expanding the scope and elevating the level of collaboration between enterprises.
Changsen Pharma is dedicated to independently developing first-in-class, best-in-class innovative drugs with global intellectual property rights to address unmet clinical needs.
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
"Private funds raise capital only from specific qualified investors who meet certain criteria." Qiming Venture Partners reminds all investors and entrepreneurs to stay vigilant, verify authenticity, and avoid financial losses.
